A

Alamar Biosciences, Inc. Tech Stack

Automated proteomics platform for high-sensitivity multiplexed protein analysis

Biotechnology Research Fremont, California 51–200 employees Founded 2018 Privately Held

Alamar Biosciences builds automated immunoassay hardware and chemistry for precision protein detection. The tech stack reveals a manufacturing-and-research-first organization—SolidWorks, Benchling, and qPCR/ddPCR dominate alongside data tools (Python, R, GraphPad Prism, JMP)—with hiring concentrated in research and ops roles. Pain points center on mechanical reliability and scaling manufacturing, not software; the project list (NPI, technology transfer, automated protocols, instrument improvements) confirms the company is in active hardware refinement and commercial ramp, not platform diversification.

Tech Stack 30 technologies

Core StackSolidWorks Salesforce HubSpot Power BI Python NetSuite GitHub Lucidchart Miro Greenhouse Flask Argo CD qPCR ddPCR Excel GraphPad Prism R Shiny Microsoft Office JMP Benchling SQL PowerPoint Word Visio Streamlit Git

What Alamar Biosciences, Inc. Is Building

◆Challenges

Improving mechanical reliability
Ensuring on-time deliveries
Scalable customer support processes
Meeting commercial targets
Maintaining inventory levels
Expanding commercial organization
Sustaining current proteomics platform
Improving biomarker detection sensitivity
Generating leads
Instrument maintenance and upgrades

▲Active Projects

New product introductions (npi)
Cutting-edge immunoassay-based protein quantification technologies
Technical work instructions and manuals
Automated assay protocols
Technology transfer initiatives
Regional digital marketing campaigns
Sales enablement tools
Single-plex nulisa immunoassay projects
Scalable customer support processes
Mechanical reliability improvement projects

Hiring Activity

Accelerating50 roles · 30 in 30d

Department

Research

10

Ops

8

Sales

7

Engineering

6

Manufacturing

5

Product

4

Support

4

Finance

2

Seniority

Senior

13

Mid

12

Junior

11

Intern

6

Manager

4

Director

3

Lead

1

Company intelligence

Find more companies like Alamar Biosciences, Inc. by tech stack, pain points and active projects

Get started free

About Alamar Biosciences, Inc.

Alamar Biosciences develops automated systems for multiplexed protein analysis, targeting immunology and inflammation research. The core offering combines proprietary NULISA Chemistry (a sequential capture-and-release method designed to reduce background noise and expand dynamic range) with the ARGO automation platform, which enables fully automated workflows in under 30 minutes of hands-on time per sample. The NULISAseq panel measures 200+ immune and inflammatory markers. The company operates across R&D, manufacturing, commercial sales, and customer support, with hiring activity spanning North America, Europe, and Asia-Pacific.

HeadquartersFremont, California

Company Size51–200 employees

Founded2018

Hiring MarketsUnited States, Singapore, France, Germany, China, Japan, Australia

Frequently Asked Questions

What is Alamar Biosciences' core technology?

NULISA Chemistry, a sequential capture-and-release method for protein detection with reduced background and increased sensitivity and dynamic range, paired with the ARGO automated system for sample-to-data workflows in under 30 minutes.

What is the NULISAseq Inflammation Panel?

A multiplex immunoassay that measures 200+ biomarkers related to immune and inflammatory diseases, designed to run on the ARGO platform with both qPCR and NGS readout options.